MDGL
NASDAQ · Biotechnology
Madrigal Pharmaceuticals Inc
$510.04
-24.82 (-4.64%)
Performance
1D
—
1W
—
1M
—
3M
+6.52%
6M
-3.57%
1Y
+69.58%
YTD
-14.12%
Open$535.00
Previous Close$534.86
Day High$541.57
Day Low$510.00
52W High$615.00
52W Low$265.00
Volume—
Avg Volume268.7K
Market Cap12.27B
P/E Ratio—
EPS$-12.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$526.21
Below
SMA 200
$421.32
Above
RSI (14)
32.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-76.5% upside
Current
$510.04
$510.04
Target
$119.83
$119.83
$78.20
$119.83 avg
$127.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.03B | 3.52B | 3.21B |
| Net Income | -309,125,753 | -1,086,916,353 | -1,008,552,409 |
| Profit Margin | -30.1% | -30.9% | -31.4% |
| EBITDA | -323,655,753 | -994,214,061 | -913,486,769 |
| Free Cash Flow | — | -874,407,524 | -958,278,915 |
| Rev Growth | — | +9.6% | -7.9% |
| Debt/Equity | 0.56 | 0.46 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |